Russia and Cuba Collaborate on New Cancer Vaccine

Russia and Cuba have formalized a partnership to develop a new cancer vaccine through a memorandum signed by Russian Deputy Prime Minister Dmitri Chernyshenko. This agreement was unveiled during the 2026 St.

Petersburg International Economic Forum, emphasizing the strengthening of scientific and healthcare collaboration between the two nations. Over the past year, Russia has supplied Cuba with hundreds of pharmaceutical substances to enhance the island's medical manufacturing capacity and support ongoing healthcare initiatives.

The joint research project will involve Russian and Cuban medical institutions, focusing on cancer treatment, innovative therapies, and the design of biosimilar medicines targeting specific tumor types. Preliminary studies involving monoclonal antibody-based treatments have shown promising results for treating cancers such as melanoma and lymphoma.

Officials expect this agreement to expand cooperation in clinical research and biotechnology, reflecting a growing global push for international partnerships in cancer treatment and medical innovation.